Volunteer

A biosimilar insulin is like a generic version of insulin. It works the same way as the original, is just as safe and effective, and is approved by the FDA. The difference is that it can be made and sold at a lower cost once the original patent expires.

Our insulin is biosimilar (generic) glargine, proven effective, but produced and distributed directly by us to ensure affordability and reliability.

We are raising $750,000–$1,000,000 right now. This money will pay for the scientific and regulatory steps we need to develop our insulin and cover early operations so we can move closer to bringing affordable insulin to patients.

The science to make insulin is well known, the patents have expired, and the tools already exist. What is missing is the will to act—and we are no longer waiting for someone else to fix the problem.

We’re supported by grants, donors, and aligned investors. The money goes straight to the work. Consider investing in Project Insulin.

You can support us by donating, volunteering your skills, or simply spreading the word. Every bit of support brings affordable insulin closer to those who need it most.